JP2005507381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507381A5 JP2005507381A5 JP2003523181A JP2003523181A JP2005507381A5 JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5 JP 2003523181 A JP2003523181 A JP 2003523181A JP 2003523181 A JP2003523181 A JP 2003523181A JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- dibromo
- isopropyl
- hydroxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0120691A GB0120691D0 (en) | 2001-08-24 | 2001-08-24 | Novel Compounds |
| GB0207719A GB0207719D0 (en) | 2002-04-03 | 2002-04-03 | Novel compounds |
| PCT/EP2002/009120 WO2003018515A2 (en) | 2001-08-24 | 2002-08-13 | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005507381A JP2005507381A (ja) | 2005-03-17 |
| JP2005507381A5 true JP2005507381A5 (enExample) | 2006-06-22 |
Family
ID=26246475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003523181A Pending JP2005507381A (ja) | 2001-08-24 | 2002-08-13 | 心臓障害および代謝障害の治療のための主要環置換甲状腺受容体アンタゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7279593B2 (enExample) |
| EP (1) | EP1499578A2 (enExample) |
| JP (1) | JP2005507381A (enExample) |
| KR (1) | KR20040027927A (enExample) |
| AU (1) | AU2002331145B2 (enExample) |
| CA (1) | CA2449515A1 (enExample) |
| IL (1) | IL159006A0 (enExample) |
| WO (1) | WO2003018515A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002336532C1 (en) | 2001-09-14 | 2008-10-16 | Amgen, Inc | Linked biaryl compounds |
| JP2007512359A (ja) | 2003-11-19 | 2007-05-17 | メタバシス・セラピューティクス・インコーポレイテッド | 新規なリン含有甲状腺ホルモン様物質 |
| GB0406380D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
| CA2606499C (en) | 2005-05-26 | 2017-06-13 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
| BRPI1015096A2 (pt) | 2009-04-20 | 2016-05-03 | Mitsubishi Tanabe Pharma Corp | agonista de receptor beta de hormônio tireoideano |
| WO2018094265A2 (en) | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| CN110996966A (zh) | 2017-06-05 | 2020-04-10 | 维京治疗公司 | 用于治疗纤维化的组合物 |
| EP3683306A4 (en) | 2017-09-14 | 2021-06-09 | Riken | METHOD FOR MANUFACTURING RETINAGE TISSUE |
| KR20200138283A (ko) | 2018-03-22 | 2020-12-09 | 바이킹 테라퓨틱스 인코포레이티드 | 결정질 형태, 및 결정질 형태의 화합물을 제조하는 방법 |
| WO2020117962A1 (en) | 2018-12-05 | 2020-06-11 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis and inflammation |
| MY206063A (en) | 2019-03-13 | 2024-11-27 | Riken | Method for evaluating quality of transplant neural retina, and transplant neural retina sheet |
| WO2022054924A1 (ja) | 2020-09-11 | 2022-03-17 | 大日本住友製薬株式会社 | 移植用組織のための媒体 |
| JPWO2022054925A1 (enExample) | 2020-09-11 | 2022-03-17 | ||
| JPWO2023090427A1 (enExample) | 2021-11-19 | 2023-05-25 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8501372D0 (en) | 1985-01-18 | 1985-02-20 | Smith Kline French Lab | Chemical compounds |
| DK0580550T3 (da) * | 1992-07-21 | 1998-02-02 | Ciba Geigy Ag | Oxamidsyrederivater som hypercholesterolæmiske midler |
| DK0831769T3 (da) * | 1995-06-07 | 2004-02-23 | Karobio Ab | Hidtil ukendte anvendelser af thyroideahormoner eller thyroideahormon-lignende forbindelser |
| GB9713739D0 (en) * | 1997-06-27 | 1997-09-03 | Karobio Ab | Thyroid receptor ligands |
| GB9816935D0 (en) | 1998-08-05 | 1998-09-30 | Karobio Ab | Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders |
| GB9828442D0 (en) * | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| GB9927056D0 (en) * | 1999-11-17 | 2000-01-12 | Karobio Ab | Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| TR200202249T2 (tr) | 2000-03-31 | 2003-01-21 | Pfizer Products Inc. | Tiroit reseptörü ligantları olarak malonik asitler ve bunların türevleri |
| WO2001085670A1 (en) | 2000-05-12 | 2001-11-15 | Kissei Pharmaceutical Co., Ltd. | Malonanilic acid derivatives, medicinal compositions containing the same and use thereof |
-
2002
- 2002-08-13 JP JP2003523181A patent/JP2005507381A/ja active Pending
- 2002-08-13 AU AU2002331145A patent/AU2002331145B2/en not_active Ceased
- 2002-08-13 IL IL15900602A patent/IL159006A0/xx unknown
- 2002-08-13 EP EP02767384A patent/EP1499578A2/en not_active Withdrawn
- 2002-08-13 US US10/485,849 patent/US7279593B2/en not_active Expired - Fee Related
- 2002-08-13 KR KR10-2004-7002447A patent/KR20040027927A/ko not_active Ceased
- 2002-08-13 WO PCT/EP2002/009120 patent/WO2003018515A2/en not_active Ceased
- 2002-08-13 CA CA002449515A patent/CA2449515A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005507381A5 (enExample) | ||
| JP2005522476A5 (enExample) | ||
| JP2004533450A5 (enExample) | ||
| JP2020075939A5 (enExample) | ||
| JP2004529174A5 (enExample) | ||
| JP2007502806A5 (enExample) | ||
| JP2017504642A5 (enExample) | ||
| JP2019537605A5 (enExample) | ||
| CA2683738A1 (en) | Indanone derivatives that inhibit prolyl hydroxylase | |
| JP2005528393A5 (enExample) | ||
| JP2014502972A5 (enExample) | ||
| JP2004534825A5 (enExample) | ||
| RU2006119510A (ru) | Фенильные производные в качестве ppar агонистов | |
| JP2009520769A5 (enExample) | ||
| JP2013531070A5 (enExample) | ||
| JP2017507915A5 (enExample) | ||
| JP2010522710A5 (enExample) | ||
| JP2015508068A5 (enExample) | ||
| JP2005521721A5 (enExample) | ||
| JP2008512408A5 (enExample) | ||
| JP2018525371A5 (enExample) | ||
| JP2020504120A5 (enExample) | ||
| JP2007515467A5 (enExample) | ||
| JPWO2021076890A5 (enExample) | ||
| JP2019516709A5 (enExample) |